Home About us Contact | |||
Sessions
Kinds of Sessions Terms modified by Sessions Selected AbstractsAcyclovir-induced neuropsychosis successfully recovered after immediate hemodialysis in an end-stage renal disease patientINTERNATIONAL JOURNAL OF DERMATOLOGY, Issue 8 2007Hung-Hsu Yang MD A 70-year-old man developed herpes zoster over the right L5,S2 region for 3 days and was admitted for acyclovir therapy. He had a medical history of rectal cancer status post-colostomy and end-stage renal disease undergoing thrice weekly hemodialysis. Without a prior loading dose, acyclovir 500 mg (7.7 mg/kg) daily was given intravenously in two divided doses. On the third dosage, the patient became confused and agitated and developed insomnia. Within the following 24 h, delirium, visual and auditory hallucinations, disorientation to place and time, as well as impaired recent memory occurred. At the same time, a transient low grade fever (38 °C) was noted but resolved spontaneously after ice pillow (Fig. 1). Figure 1. The clinical and treatment course of the patient The etiology was vigorously explored. He had no history of any neurological or psychiatric disorders. Drug history was reviewed, but no other medications besides acyclovir were currently being used. Physical examination revealed neither meningeal signs nor focal neurological deficits. Serum blood urea nitrogen, glucose, and electrolytes were within normal limits except for an elevated creatinine level at 6.2 and 5.7 mg/dl (before and after neuropsychotic symptoms, respectively). Complete blood count with differentiation was also unremarkable. Cerebrospinal fluid examination was not possible as the patient's family refused the lumbar puncture. Moreover, an electroencephalograph study and head computed tomography scan disclosed no abnormalities. Acyclovir-induced neurotoxicity was suspected. Therefore, acyclovir was discontinued. Subsequently, serum acyclovir and CMMG were checked by enzyme-linked immunosorbent assay. Serum acyclovir level was 1.6 mg/l (normal therapeutic level, 0.12,10.8 mg/l) and CMMG level was 5 mg/l. Emergent hemodialysis (4-h/session) was given; the neuropsychotic symptoms, including agitation, delirium, and visual and auditory hallucinations, greatly abated after the second session. The patient fully recovered after three consecutive days of hemodialysis; the serum was rechecked and revealed that the acyclovir level was below 0.5 mg/l and the CMMG level was undetectable. At the same time, his herpetic skin lesions resolved well. [source] Seventh Americas Hepatopancreatobiliary Congress ANNUAL SCIENTIFIC SESSION & POST GRADUATE PROGRAM April 19,22, 2007 Bally's Hotel Las Vegas, NevadaHPB, Issue 2007Article first published online: 17 FEB 200 First page of article [source] SESSION 1 Drug DeliveryJOURNAL OF PHARMACY AND PHARMACOLOGY: AN INTERNATI ONAL JOURNAL OF PHARMACEUTICAL SCIENCE, Issue S1 2006Article first published online: 18 FEB 2010 First page of article [source] FIRST INTERVIEWAND ONE SESSION WITH ,ANA'THE INTERNATIONAL JOURNAL OF PSYCHOANALYSIS, Issue 3 2002ELIAS M. DA ROCHA BARROS First page of article [source] PLENARY SESSION: ,THE LINK AND THE OTHER'THE INTERNATIONAL JOURNAL OF PSYCHOANALYSIS, Issue 3 2002Jane Milton No abstract is available for this article. [source] BEST FREE PAPER SESSIONSACTA ANAESTHESIOLOGICA SCANDINAVICA, Issue 2005Article first published online: 24 JUN 200 First page of article [source] ASNE DAY 2008 , TECHNICAL PAPER SESSIONSNAVAL ENGINEERS JOURNAL, Issue 4 2008Article first published online: 7 APR 200 No abstract is available for this article. [source] THE ANALYST AT WORK: TWO SESSIONS WITH ALBATHE INTERNATIONAL JOURNAL OF PSYCHOANALYSIS, Issue 4 2002Stefano Bolognini In this paper, the author presents clinical material that relates to two sessions with a patient called Alba. This analytic work, being of a somewhat unusual character, lends itself to discussion, the author feels, since the technical choices made are undoubtedly very personal and he believes many colleagues might have done things differently. The author endeavours to enrich the account of the sessions with his concomitant thoughts, so as to supply colleagues with the elements, atmosphere and developments of his internal workshop. [source] Session A: Cerebral Palsy: a Population-Based International PerspectiveDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 2010Article first published online: 1 SEP 2010 First page of article [source] Session 1: Wednesday 16 January 2008DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 2008Article first published online: 17 DEC 200 No abstract is available for this article. [source] Session A: Musculoskeletal/GaitDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 2006Article first published online: 12 NOV 200 First page of article [source] Session A: Orthopaedic Surgery and GaitDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 9 2005Article first published online: 13 FEB 200 First page of article [source] Session A: Orthopaedic Surgery and GaitDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 2005Article first published online: 12 NOV 200 First page of article [source] Session A: Cerebral Palsy Outcome ToolsDEVELOPMENTAL MEDICINE & CHILD NEUROLOGY, Issue 2004Article first published online: 6 NOV 200 First page of article [source] Ten years after the United Nations General Assembly Special Session (UNGASS): assessing drug problems, policies and reform proposalsADDICTION, Issue 4 2009Peter Reuter ABSTRACT In 1998 the United Nations General Assembly Special Session resolved that governments would reduce drug production and consumption greatly within 10 years. With that period now elapsed, there is an interest in reviewing how successful this was and considering how drug policy could be improved. The demand for drugs in the world has stabilized mainly as a result of the interaction of epidemic forces, culture and economic development. Supply has become more concentrated and the menu of drugs has changed surprisingly slowly. Drug policy is shifting to a more explicitly tolerant configuration in Europe and a few other countries, but retains its ferocity in most of the world. The most prominent innovations under discussion have limited potential effects (heroin maintenance), have as yet been unproductive of policy interventions (,addiction is a brain disease') or have no political appeal (legalization). The option with the most scope is increased effort at diverting arrested drug users out of criminal justice systems. No prevention, treatment or enforcement strategies have demonstrated an ability to substantially affect the extent of drug use and addiction. The best that government interventions can do is to reduce the damaging consequences of drug use and drug control. More attention should be given to reductions in the intensity of drug enforcement, which has many unintended adverse consequences and yields few of the claimed gains. [source] Saturday, December 5, 2009 Investigators' Workshop Saturday Evening Session 6:00 p.m.-8:00 p.m.EPILEPSIA, Issue 2009Article first published online: 6 OCT 200 No abstract is available for this article. [source] Sunday, December 6, 2009 Poster Session 2 8:00 a.m.-6:00 p.m.EPILEPSIA, Issue 2009Article first published online: 6 OCT 200 First page of article [source] Using innovative group-work activities to enhance the problem-based learning experience for dental studentsEUROPEAN JOURNAL OF DENTAL EDUCATION, Issue 4 2009R. Grady Abstract Problem-based learning (PBL) in medical and dental curricula is now well established, as such courses are seen to equip students with valuable transferable skills (e.g. problem-solving or team-working abilities), in addition to knowledge acquisition. However, it is often assumed that students improve in such skills without actually providing direct opportunity for practice, and without giving students feedback on their performance. ,The Manchester Dental Programme' (TMDP) was developed at The University of Manchester, UK as a 5-year, integrated enquiry-led curriculum. The existing PBL course was redesigned to include a unique, additional PBL session (,Session 4') that incorporated an activity for the group to complete, based on the subject material covered during student self-study. A summative mark was awarded for each activity that reflected the teamwork, organisational and overall capabilities of the groups. This paper describes the different types of activities developed for the Session 4 and presents an analysis of the perceptions of the students and staff involved. The student response to the Session 4 activities, obtained via questionnaires, was extremely positive, with the majority finding them fun, yet challenging, and ,worthwhile'. The activities were perceived to enhance subject understanding; develop students' problem-solving skills; allow the application of knowledge to new situations, and helped to identify gaps in knowledge to direct further study. Staff found the activities innovative and exciting learning tools for the students. The Session 4 activities described here are useful educational resources that could be adapted for other PBL courses in a wide variety of subject areas. [source] Poster Session 1, Sunday 5 SeptemberEUROPEAN JOURNAL OF NEUROLOGY, Issue 2004Article first published online: 27 AUG 200 First page of article [source] Poster Session 2, Monday 6 SeptemberEUROPEAN JOURNAL OF NEUROLOGY, Issue 2004Article first published online: 27 AUG 200 First page of article [source] Session 7: Innate and adaptive immune responses to microbes at mucosal surfacesIMMUNOLOGY, Issue 2007Article first published online: 8 FEB 200 First page of article [source] Session 8: Architecture and migration in the immune responseIMMUNOLOGY, Issue 2007Article first published online: 8 FEB 200 No abstract is available for this article. [source] Session 1: Respiratory pathogens and vaccination strategiesIMMUNOLOGY, Issue 2004Article first published online: 26 NOV 200 First page of article [source] Session 2: Macrophages: polarisation during immune responses and tissue damageIMMUNOLOGY, Issue 2004Article first published online: 26 NOV 200 No abstract is available for this article. [source] Session 18: The immunobiology of sepsisIMMUNOLOGY, Issue 2004Article first published online: 26 NOV 200 No abstract is available for this article. [source] Session 19: Clinical immunology of psoriasisIMMUNOLOGY, Issue 2004Article first published online: 26 NOV 200 No abstract is available for this article. [source] Session 20: Good Practice in undergraduate educationIMMUNOLOGY, Issue 2004Article first published online: 26 NOV 200 No abstract is available for this article. [source] Session 01: Antigen processingIMMUNOLOGY, Issue 2001Article first published online: 28 JUN 200 No abstract is available for this article. [source] Session 02: Regulatory T cellsIMMUNOLOGY, Issue 2001Article first published online: 28 JUN 200 No abstract is available for this article. [source] Session 03: Liver immunologyIMMUNOLOGY, Issue 2001Article first published online: 28 JUN 200 No abstract is available for this article. [source] |